Evidence map›Paper›PMID 31290194›Full record

ArticleMolecular microbiology2019

SosA inhibits cell division in Staphylococcus aureus in response to DNA damage.

Martin S Bojer, Katarzyna Wacnik, Peter Kjelgaard, Clement Gallay, Amy L Bottomley, Marianne T Cohn, Gunnar Lindahl, Dorte Frees, Jan-Willem Veening, Simon J Foster and 1 more

Abstract read
In one paragraph

Article in Molecular microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. SroA links SigS-dependent stress signaling to metabolic remodeling inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. mLife · 2024
    Review
  6. The global RNA-RNA interactome ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Defining Membrane Protein Topology Using pho-lac Reporter Fusions.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. A Clinically Selected Staphylococcus aureusAntimicrobial agents and chemotherapy · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Exploration of inhibitors of the bacterial LexA repressor-protease.Bioorganic & medicinal chemistry letters · 2022
    Article
  14. Review
  15. Review
  16. Regulation of Heterogenous LexA Expression inInternational journal of molecular sciences · 2022
    Article
  17. Sending out an SOS - the bacterial DNA damage response.Genetics and molecular biology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Martin S BojerDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-8488-9593
Katarzyna WacnikDepartment of Molecular Biology and Biotechnology, The Krebs Institute, University of Sheffield, Sheffield, UK.
Peter KjelgaardDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Clement GallayDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Amy L BottomleyDepartment of Molecular Biology and Biotechnology, The Krebs Institute, University of Sheffield, Sheffield, UK.
Marianne T CohnDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Gunnar LindahlDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Dorte FreesDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jan-Willem VeeningDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0002-3162-6634
Simon J FosterDepartment of Molecular Biology and Biotechnology, The Krebs Institute, University of Sheffield, Sheffield, UK.
Hanne IngmerDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Funding

Medical Research Council G1100127Medical Research Council MR/K015753/1Medical Research Council MR/N002679/1
6 · The paper itself

Abstract

Inhibition of cell division is critical for viability under DNA-damaging conditions. DNA damage induces the SOS response that in bacteria inhibits cell division while repairs are being made. In coccoids, such as the human pathogen, Staphylococcus aureus, this process remains poorly studied. Here, we identify SosA as the staphylococcal SOS-induced cell division inhibitor. Overproduction of SosA inhibits cell division, while sosA inactivation sensitizes cells to genotoxic stress. SosA is a small, predicted membrane protein with an extracellular C-terminal domain in which point mutation of residues that are conserved in staphylococci and major truncations abolished the inhibitory activity. In contrast, a minor truncation led to SosA accumulation and a strong cell division inhibitory activity, phenotypically similar to expression of wild-type SosA in a CtpA membrane protease mutant. This suggests that the extracellular C-terminus of SosA is required both for cell division inhibition and for turnover of the protein. Microscopy analysis revealed that SosA halts cell division and synchronizes the cell population at a point where division proteins such as FtsZ and EzrA are localized at midcell, and the septum formation is initiated but unable to progress to closure. Thus, our findings show that SosA is central in cell division regulation in staphylococci.

Indexed as

Bacterial ProteinsCell DivisionCytoskeletal ProteinsDNA DamageMembrane ProteinsSOS Response, GeneticsStaphylococcal InfectionsStaphylococcus aureusBacterial ProteinsCytoskeletal ProteinsMembrane Proteins

Identifiers

PMID31290194
PMCPMC6851548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.